COPE/CE - Modern Optometry

Episodes 1-16 of 37

Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
CME/CE
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Christina Y. Weng, MD, MBA, FASRS; Mark T. Dunbar, OD, FAAO
1.00 credit
Christina Y. Weng, MD, MBA, FASRS; Mark T. Dunbar, OD, FAAO
1.00 credit
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
CME/CE
Improving Outcomes and Coordinating Care in Diabetic Retinopathy and Diabetic Macular Edema
John Kitchens, MD; Sara LeMay, OD
0.25 credits
John Kitchens, MD; Sara LeMay, OD
0.25 credits
Biomarkers and Second-Generation Treatments
Biomarkers and Second-Generation Treatments
CME/CE
Biomarkers and Second-Generation Treatments
John W. Kitchens, MD; Sara LeMay, OD
0.25 credits
John W. Kitchens, MD; Sara LeMay, OD
0.25 credits
Shared Care Perspectives: Retina and Optometry
Shared Care Perspectives: Retina and Optometry
CME/CE
Shared Care Perspectives: Retina and Optometry
John Kitchens, MD; Sara LeMay, OD
0.25 credits
John Kitchens, MD; Sara LeMay, OD
0.25 credits
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
COPE ACCREDITED CE OFFERED
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
Arshad M. Khanani MD, MA, FASRS; Veeral Sheth, MD, MBA, FASRS, FACS
1.00 credit
Arshad M. Khanani MD, MA, FASRS; Veeral Sheth, MD, MBA, FASRS, FACS
1.00 credit
Overcoming Treatment Plateaus in Chronic DME
Overcoming Treatment Plateaus in Chronic DME
CME/CE
Overcoming Treatment Plateaus in Chronic DME
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
The Role of Presbyopia-Correcting Drops
The Role of Presbyopia-Correcting Drops
CME/CE
The Role of Presbyopia-Correcting Drops
Mark T. Dunbar, OD, FAAO; David Eichenbaum, MD
0.25 credits
Mark T. Dunbar, OD, FAAO; David Eichenbaum, MD
0.25 credits
Presbyopia-Correcting Drops: The Importance of Patient Selection
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
Achieving Durable Outcomes in Treatment-Naïve nAMD
Achieving Durable Outcomes in Treatment-Naïve nAMD
CME/CE
Achieving Durable Outcomes in Treatment-Naïve nAMD
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Retina Specialist Perspectives
Retina Specialist Perspectives
CME/CE
Retina Specialist Perspectives
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
Sunir J. Garg, MD, FACS, FASRS; Charles C. Wykoff, MD, PhD, FACS
0.25 credits
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
CME/CE Broadcast Replay
The Comanagement Plan: Elevating Retinal Care Through Unified Vision
Sunir J. Garg, MD, FACS, FASRS; John W. Kitchens, MD
1.00 credit
Sunir J. Garg, MD, FACS, FASRS; John W. Kitchens, MD
1.00 credit
Tracking GA Development: From Initial Symptoms to Treatment Approaches
Tracking GA Development: From Initial Symptoms to Treatment Approaches
CME/CE
Tracking GA Development: From Initial Symptoms to Treatment Approaches
Elizabeth (Beth) Richter, MD, PhD; Julie Rodman, OD, MSc
1.00 credit
Elizabeth (Beth) Richter, MD, PhD; Julie Rodman, OD, MSc
1.00 credit
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Kathleen N. Moore, MD, MS, FASCO; Aaron Samuel Gold, OD, FAAO
1.00 credit
Kathleen N. Moore, MD, MS, FASCO; Aaron Samuel Gold, OD, FAAO
1.00 credit
Understanding Antibody-Drug Conjugates (ADCs)
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
Aaron Samuel Gold, OD, FAAO; Carlo J. Pelino, OD, FAAO
0.25 credits
Aaron Samuel Gold, OD, FAAO; Carlo J. Pelino, OD, FAAO
0.25 credits
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Aaron Samuel Gold, OD, FAAO; Timothy G. Murray, MD, MBA, FASRS
0.25 credits
Aaron Samuel Gold, OD, FAAO; Timothy G. Murray, MD, MBA, FASRS
0.25 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Kathleen N. Moore, MD, MS, FASCO; Kamran M. Riaz, MD
0.25 credits
Kathleen N. Moore, MD, MS, FASCO; Kamran M. Riaz, MD
0.25 credits

Prev
1
2
3
Next

1/3